Beta Bionics, Inc.（BBNX）资讯与事件BBNXBeta Bionics, Inc.

Beta Bionics Partners with Senseonics for New System Launch

Beta Bionics (BBNX) announced a partnership to integrate the iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' (SENS) Eversense 365 continuous glucose monitoring system. Commercial launch of the integrated iLet and Eversense 365 system is expected in the fourth quarter of 2026, at which time Beta Bionics expects iLet to support the most CGM manufacturer options of any AID system.

Stocks Inch Higher as Markets Assess Rate Hike Impact

Stocks inched higher on Wednesday morning, pausing the week's pullback as markets assessed how the economy may fare against higher interest rates. The Federal Reserve is expected to raise interest rates by 25 basis points later today, although the summary of economic projections - or "dot plot" - is likely to show a fragmented FOMC as uncertain outlooks spark disagreements on policy and forward guidance. Hawkish concerns were further stoked with the release of strong retail sales and soaring import inflation figures this morning.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:OpenAI has held early conversations with investors aboutround at a $1.2T valuation before its planned IPO, Financial Times saysSK Hynixis in talks with Intelabout a deal toin the U.S. for the first time, Reuters reportsAppleis developing anusing its own chips and potentially Nvidianetworking equipment, The Information saysStarbucksisof a majority stake in its Japan business, Reuters reportsTrucker J.B. Hunton Q3 earnings being hurt by higher costs2. WALL STREET CALLS:Alvotechto Overweight from Underweight at BarclaysStellantisto Hold from Buy at BerenbergSimilarwebto Buy from Hold at NeedhamExpediawith Underweight from Equal Weight at Morgan StanleyCiti opened an "upside" on Metaahead of the company's Connect conference on September 233. AROUND THE WEB:Nvidia, MetaCEOs argue against AI slowdown, FT reportsMucinex and Lysol maker Reckitt Benckiserplans to invest about $400M more over the next four years in the U.S. to speed up product innovation and demand response, WSJ reportsChicago District Judge John Tharp dissolved a previous order that required multiple listings service provider Midwest Real Estate Data to temporarily maintain Zillow'saccess to listings, Bloomberg saysMetaplans to release a camera-free pair of smart glasses this fall, The Information reportsGoogleis giving all its engineers access to Anthropic's Claude Opus 5 via Antigravity, and says "Gemini remains our primary and foundational model for internal development," Business Insider says4. MOVERS:Beta Bionicsincreases after announcing aTormgains in New York after announcing Hafniahas4.5M of its sharesBloom Energyhigher after"The New Rules of AI Power" reportBraskemfalls after UBSthe stock to SellBorr Drillinglower afteron the Odin5. EARNINGS/GUIDANCE:LuxExperiencewith EPS lower year-over-yearHuntington Bancsharesfor FY27Mercury Systemsfor FY27Trip.com, with CEO Jane Sun commenting the company delivered a "resilient performance" in Q2Ispire Technology, with EPS and revenue higher year-over-yearINDEXES:Near midday, the Dow was up 37.94, or 0.07%, to 52,131.05, the Nasdaq was up 210.74, or 0.81%, to 26,192.31, and the S&P 500 was up 33.90, or 0.45%, to 7,619.63.

Deal Size Increased to $150M in Common Stock

The deal size was increased to $150M in common stock from $125M in common stock and priced within the $17.00-$17.50 range. JPMorgan, Piper Sandler, Wells Fargo and Leerink acted as joint book running managers for the offering.